FDA Enables Treatment For Thyroid Eye Disease
Yesterday the U.S. Food and Drug Administration (FDA) accepted Tepezza (teprotumumab-trow) for the processing of adults with a thyroid eye disorder, a rare condition where…
Read MoreProducts
ICI Treatments Being Efficient In The Sufferers with HIV, HBV, HCV
Bioingestible Sensors for Medication Adherence: The Current Status?
Annual AJMC® Health IT Point Embraces Machine Learning, Telehealth, And Portable Licensure
Minoxidil market to gain traction via soaring popularity of 2% based product sales
OTC Medicine: The Upgrade Is Done
FDA New Supplement Test: Know It Now!
Trividia Health: Diabetes Improvement
Bryn Pharma, LLC Has Announced The Latest News
Luye Pharma: New Medicine Implementation
Luye Pharma Group has published the submission of a new medication questionnaire (NDA) to the U.S. Food and Drug Administration (FDA) for LY03005, a new…